Fenoldopam in newborn patients undergoing cardiopulmonary bypass: Controlled clinical trial

Zaccaria Ricci, Giulia V. Stazi, Luca Di Chiara, Stefano Morelli, Vincenzo Vitale, Chiara Giorni, Claudio Ronco, Sergio Picardo

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

We determined if low dose fenoldopam in neonates already receiving conventional diuretics improves urine output, fluid balance, acute kidney injury incidence (AKI) and time to extubation. A prospective controlled clinical trial in a pediatric cardiac intensive care unit on 40 neonates undergoing cardiac surgery with cardiopulmonary bypass, excluding simple ventricular septal defect and atrial septal defect. Fenoldopam was infused at a low dose of 0.1 μg/kg/min soon after anesthesia induction and infusion prolonged for 72 h in 20 patients. Twenty neonates with standardized perioperative therapy except fenoldopam administration served as controls. Demographic, hemodynamic, daily urine output, creatinine, creatinine clearance, serum and urinary sodium and potassium were recorded. Inotropic score (IS) was calculated as a surrogate for the degree of hemodynamic impairment. Low dose fenoldopam infusion did not show beneficial effects in renal function. The treatment did not significantly affect IS value, AKI incidence, fluid balance control, time to sternal closure, time to extubation and time to intensive care unit discharge. Low dose fenoldopam in neonates undergoing cardiac surgery with CPB did not produce effects on urine output, fluid balance and AKI incidence. Fenoldopam was well tolerated and did not negatively affect hemodynamics and vasopressor support.

Original languageEnglish
Pages (from-to)1049-1053
Number of pages5
JournalInteractive Cardiovascular and Thoracic Surgery
Volume7
Issue number6
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Fenoldopam
Controlled Clinical Trials
Cardiopulmonary Bypass
Newborn Infant
Water-Electrolyte Balance
Acute Kidney Injury
Incidence
Hemodynamics
Urine
Thoracic Surgery
Creatinine
Pediatric Intensive Care Units
Atrial Heart Septal Defects
Ventricular Heart Septal Defects
Diuretics
Intensive Care Units
Potassium
Anesthesia
Sodium
Demography

Keywords

  • Acute kidney injury
  • Cardiopulmonary bypass
  • Congenital heart disease
  • Fenoldopam

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Fenoldopam in newborn patients undergoing cardiopulmonary bypass : Controlled clinical trial. / Ricci, Zaccaria; Stazi, Giulia V.; Di Chiara, Luca; Morelli, Stefano; Vitale, Vincenzo; Giorni, Chiara; Ronco, Claudio; Picardo, Sergio.

In: Interactive Cardiovascular and Thoracic Surgery, Vol. 7, No. 6, 12.2008, p. 1049-1053.

Research output: Contribution to journalArticle

@article{148dc24144804c79ad189ac76b9f8f17,
title = "Fenoldopam in newborn patients undergoing cardiopulmonary bypass: Controlled clinical trial",
abstract = "We determined if low dose fenoldopam in neonates already receiving conventional diuretics improves urine output, fluid balance, acute kidney injury incidence (AKI) and time to extubation. A prospective controlled clinical trial in a pediatric cardiac intensive care unit on 40 neonates undergoing cardiac surgery with cardiopulmonary bypass, excluding simple ventricular septal defect and atrial septal defect. Fenoldopam was infused at a low dose of 0.1 μg/kg/min soon after anesthesia induction and infusion prolonged for 72 h in 20 patients. Twenty neonates with standardized perioperative therapy except fenoldopam administration served as controls. Demographic, hemodynamic, daily urine output, creatinine, creatinine clearance, serum and urinary sodium and potassium were recorded. Inotropic score (IS) was calculated as a surrogate for the degree of hemodynamic impairment. Low dose fenoldopam infusion did not show beneficial effects in renal function. The treatment did not significantly affect IS value, AKI incidence, fluid balance control, time to sternal closure, time to extubation and time to intensive care unit discharge. Low dose fenoldopam in neonates undergoing cardiac surgery with CPB did not produce effects on urine output, fluid balance and AKI incidence. Fenoldopam was well tolerated and did not negatively affect hemodynamics and vasopressor support.",
keywords = "Acute kidney injury, Cardiopulmonary bypass, Congenital heart disease, Fenoldopam",
author = "Zaccaria Ricci and Stazi, {Giulia V.} and {Di Chiara}, Luca and Stefano Morelli and Vincenzo Vitale and Chiara Giorni and Claudio Ronco and Sergio Picardo",
year = "2008",
month = "12",
doi = "10.1510/icvts.2008.185025",
language = "English",
volume = "7",
pages = "1049--1053",
journal = "Interactive Cardiovascular and Thoracic Surgery",
issn = "1569-9293",
publisher = "European Association for Cardio-Thoracic Surgery",
number = "6",

}

TY - JOUR

T1 - Fenoldopam in newborn patients undergoing cardiopulmonary bypass

T2 - Controlled clinical trial

AU - Ricci, Zaccaria

AU - Stazi, Giulia V.

AU - Di Chiara, Luca

AU - Morelli, Stefano

AU - Vitale, Vincenzo

AU - Giorni, Chiara

AU - Ronco, Claudio

AU - Picardo, Sergio

PY - 2008/12

Y1 - 2008/12

N2 - We determined if low dose fenoldopam in neonates already receiving conventional diuretics improves urine output, fluid balance, acute kidney injury incidence (AKI) and time to extubation. A prospective controlled clinical trial in a pediatric cardiac intensive care unit on 40 neonates undergoing cardiac surgery with cardiopulmonary bypass, excluding simple ventricular septal defect and atrial septal defect. Fenoldopam was infused at a low dose of 0.1 μg/kg/min soon after anesthesia induction and infusion prolonged for 72 h in 20 patients. Twenty neonates with standardized perioperative therapy except fenoldopam administration served as controls. Demographic, hemodynamic, daily urine output, creatinine, creatinine clearance, serum and urinary sodium and potassium were recorded. Inotropic score (IS) was calculated as a surrogate for the degree of hemodynamic impairment. Low dose fenoldopam infusion did not show beneficial effects in renal function. The treatment did not significantly affect IS value, AKI incidence, fluid balance control, time to sternal closure, time to extubation and time to intensive care unit discharge. Low dose fenoldopam in neonates undergoing cardiac surgery with CPB did not produce effects on urine output, fluid balance and AKI incidence. Fenoldopam was well tolerated and did not negatively affect hemodynamics and vasopressor support.

AB - We determined if low dose fenoldopam in neonates already receiving conventional diuretics improves urine output, fluid balance, acute kidney injury incidence (AKI) and time to extubation. A prospective controlled clinical trial in a pediatric cardiac intensive care unit on 40 neonates undergoing cardiac surgery with cardiopulmonary bypass, excluding simple ventricular septal defect and atrial septal defect. Fenoldopam was infused at a low dose of 0.1 μg/kg/min soon after anesthesia induction and infusion prolonged for 72 h in 20 patients. Twenty neonates with standardized perioperative therapy except fenoldopam administration served as controls. Demographic, hemodynamic, daily urine output, creatinine, creatinine clearance, serum and urinary sodium and potassium were recorded. Inotropic score (IS) was calculated as a surrogate for the degree of hemodynamic impairment. Low dose fenoldopam infusion did not show beneficial effects in renal function. The treatment did not significantly affect IS value, AKI incidence, fluid balance control, time to sternal closure, time to extubation and time to intensive care unit discharge. Low dose fenoldopam in neonates undergoing cardiac surgery with CPB did not produce effects on urine output, fluid balance and AKI incidence. Fenoldopam was well tolerated and did not negatively affect hemodynamics and vasopressor support.

KW - Acute kidney injury

KW - Cardiopulmonary bypass

KW - Congenital heart disease

KW - Fenoldopam

UR - http://www.scopus.com/inward/record.url?scp=57349151494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349151494&partnerID=8YFLogxK

U2 - 10.1510/icvts.2008.185025

DO - 10.1510/icvts.2008.185025

M3 - Article

C2 - 18782787

AN - SCOPUS:57349151494

VL - 7

SP - 1049

EP - 1053

JO - Interactive Cardiovascular and Thoracic Surgery

JF - Interactive Cardiovascular and Thoracic Surgery

SN - 1569-9293

IS - 6

ER -